p38MAPK: stress responses from molecular mechanisms to therapeutics
Open accessAbstract
The p38(MAPK) protein kinases affect a variety of intracellular responses, with well-recognized roles in inflammation, cell-cycle regulation, cell death, development, differentiation, senescence and tumorigenesis. In this review, we examine the regulatory and effector components of this pathway, focusing on their emerging roles in biological processes involved in different pathologies. We summarize how this pathway has been exploited for the development of therapeutics and discuss the potential obstacles of targeting this promiscuous protein kinase pathway for the treatment of different diseases. Furthermore, we discuss how the p38(MAPK) pathway might be best exploited for the development of more effective therapeutics with minimal side effects in a range of specific disease settings.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The p38/Jun stress pathway is activated by PAMPs and DAMPs, leading to the secretion of inflammatory cytokines such as IL-1, TNF, and IL-6.
“The p38/Jun stress pathway is activated by PAMPs and DAMPs, leading to the secretion of inflammatory cytokines, such as IL-1, TNF, and IL-6.101”
From The Innate Immune System in Acute and Chronic Wounds (2016) · cites this paper as [101]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219 · see citing works
A MAP Kinase Targeted by Endotoxin and Hyperosmolarity in Mammalian Cells
Han, J., Lee, J. D., Bibbs, L., & Ulevitch, R. J. (1994) · Science · doi:10.1126/science.7914033 · Cited by 2,647 · see citing works
The selectivity of protein kinase inhibitors: a further update
Bain, J., Plater, L., Elliott, M., Shpiro, N., Hastie, C. J., McLauchlan, H., Klevernic, I. V., Arthur, J. S. C., Alessi, D. R., & Cohen, P. (2007) · Biochemical Journal · doi:10.1042/bj20070797 · Cited by 2,522 · see citing works
The p38 signal transduction pathway Activation and function
Ono, K., & Han, J. (2000) · Cellular Signalling · doi:10.1016/s0898-6568(99)00071-6 · Cited by 1,571 · see citing works
Differential regulation and properties of MAPKs
Raman, M., Chen, W., & Cobb, M. H. (2007) · Oncogene · doi:10.1038/sj.onc.1210392 · Cited by 1,430 · see citing works
p38 MAP-Kinases pathway regulation, function and role in human diseases
Cuenda, A., & Rousseau, S. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.03.010 · Cited by 1,397 · see citing works
Dickkopf-1 is a master regulator of joint remodeling
Diarra, D., Stolina, M., Polzer, K., Zwerina, J., Ominsky, M. S., Dwyer, D., Korb, A., Smolen, J. S., Hoffmann, M. H., Scheinecker, C., et al. (2007) · Nature Medicine · doi:10.1038/nm1538 · Cited by 1,296 · see citing works
Kaminska, B. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2005.08.017 · Cited by 1,285 · see citing works
ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis
Tobiume, K., Matsuzawa, A., Takahashi, T., Nishitoh, H., Morita, K., Takeda, K., Minowa, O., Miyazono, K., Noda, T., & Ichijo, H. (2001) · EMBO Reports · doi:10.1093/embo-reports/kve046 · Cited by 1,213 · see citing works
p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases
Kumar, S., Boehm, J. C., & Lee, J. C. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1177 · Cited by 1,199 · see citing works
Systematic Review of the Literature
Wool, C. (2011) · Advances in Neonatal Care · doi:10.1097/anc.0b013e31821bd92d · Cited by 1,021 · see citing works
Tau phosphorylation: the therapeutic challenge for neurodegenerative disease
Hanger, D. P., Anderton, B. H., & Noble, W. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.01.003 · Cited by 965 · see citing works
Jin, S., Zhuang, Z.-Y., Woolf, C. J., & Ji, R. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-10-04017.2003 · Cited by 854 · see citing works
Phosphatase‐mediated crosstalk between MAPK signaling pathways in the regulation of cell survival
Junttila, M. R., Li, S., & Westermarck, J. (2008) · The FASEB Journal · doi:10.1096/fj.06-7859rev · Cited by 826 · see citing works
Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases
Owens, D. M., & Keyse, S. M. (2007) · Oncogene · doi:10.1038/sj.onc.1210412 · Cited by 777 · see citing works
Mapk signal specificity: The right place at the right time
Murphy, L. O., & Blenis, J. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.03.009 · Cited by 707 · see citing works
Activated Microglia Contribute to the Maintenance of Chronic Pain after Spinal Cord Injury
Hains, B. C., & Waxman, S. G. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0003-06.2006 · Cited by 641 · see citing works
Oxidative stress: the vulnerable β-cell
Lenzen, S. (2008) · Biochemical Society Transactions · doi:10.1042/bst0360343 · Cited by 535 · see citing works
Tsuda, M., Mizokoshi, A., Shigemoto‐Mogami, Y., Koizumi, S., & Inoue, K. (2003) · Glia · doi:10.1002/glia.10308 · Cited by 520 · see citing works
A CD36-dependent signaling cascade is necessary for macrophage foam cell formation
Rahaman, S. O., Lennon, D. J., Febbraio, M., Podrez, E. A., Hazen, S. L., & Silverstein, R. L. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.06.007 · Cited by 506 · see citing works
MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets
Muslin, A. J. (2008) · Clinical Science · doi:10.1042/cs20070430 · Cited by 496 · see citing works
Mechanism of p38 MAP kinase activation in vivoPreprint
Brancho, D., Tanaka, N., Jaeschke, A., Ventura, J., Kelkar, N., Tanaka, Y., Kyuuma, M., Takeshita, T., Flavell, R. A., & Davis, R. J. (2003) · Genes & Development · doi:10.1101/gad.1107303 · Cited by 490 · see citing works
Jiang, Y., Gram, H., Zhao, M. F., New, L., Gu, J., Feng, L., Padova, F. D., Ulevitch, R. J., & Han, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.48.30122 · Cited by 489 · see citing works
Kummer, J. L., Rao, P., & Heidenreich, K. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.33.20490 · Cited by 468 · see citing works
Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity
Bulavin, D. V., Demidov, O. N., Saito, S., Kauraniemi, P., Dudgeon, C., Amundson, S. A., Ambrosino, C., Sauter, G., Nebreda, Á. R., Anderson, C. W., et al. (2002) · Nature Genetics · doi:10.1038/ng894 · Cited by 437 · see citing works
The complexity of mitogen-activated protein kinases (MAPKs) made simple
Krishna, M., & Narang, H. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8170-7 · Cited by 432 · see citing works
She, Q., Bode, A. M., Ma, W., Chen, N. Y., & Dong, Z. (2001) · PubMed · Cited by 393 · see citing works
Wang, W., Chen, J. X., Liao, R., Deng, Q., Zhou, J. J., Huang, S., & Sun, P. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.10.3389-3403.2002 · Cited by 376 · see citing works
Roulston, A., Reinhard, C., Amiri, P., & Williams, L. T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.17.10232 · Cited by 371 · see citing works
p38 MAP kinase: a convergence point in cancer therapy
Olson, J. M., & Hallahan, A. R. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.01.007 · Cited by 335 · see citing works
The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling
Ananieva, O., Darragh, J., Johansen, C., Carr, J. M., McIlrath, J. M., Park, J. M., Wingate, A. D., Monk, C. E., Toth, R. L., Santos, S. G., et al. (2008) · Nature Immunology · doi:10.1038/ni.1644 · Cited by 329 · see citing works
Development in Motion: Helper T Cells at Work
Reiner, S. L. (2007) · Cell · doi:10.1016/j.cell.2007.03.019 · Cited by 312 · see citing works
p38α MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation
Ventura, J., Tenbaum, S. P., Perdiguero, E., Huth, M., Guerra, C. E., Barbacid, M., Pasparakis, M., & Nebreda, Á. R. (2007) · Nature Genetics · doi:10.1038/ng2037 · Cited by 306 · see citing works
Ferrer, I., Gómez‐Isla, T., Puig, B., Freixes, M., Ribé, E. M., Dalfó, E., & Ávila, J. (2005) · Current Alzheimer Research · doi:10.2174/1567205052772713 · Cited by 302 · see citing works
p38 MAP Kinase's Emerging Role as a Tumor Suppressor
Bulavin, D. V., & Fornace, A. J. (2004) · Advances in cancer research · doi:10.1016/s0065-230x(04)92005-2 · Cited by 290 · see citing works
Minocycline as a Neuroprotective Agent
Stirling, D. P., Koochesfahani, K. M., Steeves, J. D., & Tetzlaff, W. (2005) · The Neuroscientist · doi:10.1177/1073858405275175 · Cited by 280 · see citing works
The Potential of Adiponectin in Driving Arthritis
Ehling, A., Schäffler, A., Herfarth, H. H., Tarner, I. H., Anders, S., Distler, O., Paul, G., Distler, J. H. W., Gay, S., Schölmerich, J., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.7.4468 · Cited by 279 · see citing works
Feedback control of the protein kinase TAK1 by SAPK2a/p38α
Cheung, P., Campbell, D. G., Nebreda, Á. R., & Cohen, P. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg552 · Cited by 278 · see citing works
The pathways to tumor suppression via route p38
Han, J., & Sun, P. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.06.007 · Cited by 267 · see citing works
Tang, C., Chiu, Y., Tan, T., Yang, R., & Fu, W. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.8.5483 · Cited by 244 · see citing works
Eotaxin and eosinophil recruitment: implications for human disease
Rankin, S. M., Conroy, D. M., & Williams, T. J. (2000) · Molecular Medicine Today · doi:10.1016/s1357-4310(99)01635-4 · Cited by 242 · see citing works
Puri, P., Wu, Z., Zhang, P., Wood, L. D., Bhakta, K. S., Han, J., Feramisco, J. R., Karin, M., & Wang, J. Y. J. (2000) · Genes & Development · doi:10.1101/gad.14.5.574 · Cited by 242 · see citing works
p38 Pathway Kinases as Anti-inflammatory Drug Targets
Schindler, J. F., Monahan, J. B., & Smith, W. G. (2007) · Journal of Dental Research · doi:10.1177/154405910708600902 · Cited by 228 · see citing works
Ronkina, N., Kotlyarov, A., Dittrich‐Breiholz, O., Kracht, M., Hitti, E., Milarski, K. L., Askew, R., Marušić, S., Lin, L.-L., Gaestel, M., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01456-06 · Cited by 217 · see citing works
p38 MAPK in Development and Cancer
Bradham, C. A., & McClay, D. R. (2006) · Cell Cycle · doi:10.4161/cc.5.8.2685 · Cited by 210 · see citing works
Ferrer, I., Blanco, R. E., Carmona, M., & Puig, B. (2001) · Journal of Neural Transmission · doi:10.1007/s007020100016 · Cited by 207 · see citing works
Targeting protein kinases for the development of anti-inflammatory drugs
Cohen, P. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.01.015 · Cited by 207 · see citing works
Wang, Y., Singh, R., Lefkowitch, J. H., Rigoli, R. M., & Czaja, M. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512953200 · Cited by 206 · see citing works
The mitogen-activated protein kinases p38 and ERK1/2 are increased in lesional psoriatic skin
Johansen, C., Kragballe, K., Westergaard, M., et al. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.06304.x · Cited by 205 · see citing works
Zhou, Z., Connell, M. C., & MacEwan, D. J. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2006.12.013 · Cited by 202 · see citing works
Inhibition of p38: Has the fat lady sung?
Genovese, M. C. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24264 · Cited by 192 · see citing works
Hudmon, A., Choi, J., Tyrrell, L., Black, J. A., Rush, A. M., Waxman, S. G., & Dib‐Hajj, S. D. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.4403-07.2008 · Cited by 180 · see citing works
Zheng, Y., Niyonsaba, F., Ushio, H., Nagaoka, I., Ikeda, S., Okumura, K., & Ogawa, H. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08196.x · Cited by 175 · see citing works
Ferrer, I., Blanco, R. E., Carmona, M., Puig, B., Barrachina, M., Gómez, C., & Ambrosio, S. (2001) · Journal of Neural Transmission · doi:10.1007/s007020100015 · Cited by 172 · see citing works
Culbert, A. A., Skaper, S. D., Howlett, D. R., Evans, N. A., Facci, L., Soden, P. E., Seymour, Z. M., Guillot, F., Gaestel, M., & Richardson, J. C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513646200 · Cited by 170 · see citing works
Kim, H.-R., Cho, M.-L., Kim, K.-W., Juhn, J.-P., Hwang, S.-Y., Yoon, C.-H., Park, S.-H., Lee, S., & Kim, H.-Y. (2006) · Rheumatology · doi:10.1093/rheumatology/kel159 · Cited by 170 · see citing works
IL‐18 enhances IFN‐γ‐induced production of CXCL9, CXCL10, and CXCL11 in human keratinocytes
Kanda, N., Shimizu, T., Tada, Y., et al. (2007) · European Journal of Immunology · doi:10.1002/eji.200636420 · Cited by 169 · see citing works
Role of MAPKs in development and differentiation: lessons from knockout mice
Aouadi, M., Binétruy, B., Caron, L., MARCHAND‐BRUSTEL, Y. L., & Bost, F. (2006) · Biochimie · doi:10.1016/j.biochi.2006.06.003 · Cited by 157 · see citing works
Katsura, H., Obata, K., Mizushima, T., et al. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1771-06.2006 · Cited by 149 · see citing works
Involvement of the p38 mitogen‐activated protein kinase cascade in hepatocellular carcinoma
Iyoda, K., Sasaki, Y., Horimoto, M., Toyama, T., Yakushijin, T., Sakakibara, M., Takehara, T., Fujimoto, J., Hori, M., Wands, J. R., et al. (2003) · Cancer · doi:10.1002/cncr.11425 · Cited by 148 · see citing works
MAPKAP Kinase 2-Deficient Mice Are Resistant to Collagen-Induced Arthritis
Hegen, M., Gaestel, M., Nickerson‐Nutter, C. L., Lin, L., & Telliez, J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1913 · Cited by 147 · see citing works
Cell cycle regulation by p38 MAP kinases
Ambrosino, C., & Nebreda, Á. R. (2001) · Biology of the Cell · doi:10.1016/s0248-4900(01)01124-8 · Cited by 147 · see citing works
Haq, R., Brenton, J. D., Takahashi, M. T., Finan, D., Finkielsztein, A., Damaraju, S., Rottapel, R. K., & Zanke, B. W. (2002) · PubMed · Cited by 143 · see citing works
Korb, A., Tohidast-Akrad, M., Cetin, E., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22080 · Cited by 140 · see citing works
Johansen, C., Funding, A. T., Otkjær, K., Kragballe, K., Jensen, U. B., Madsen, M. W., Binderup, L., Skak‐Nielsen, T., Fjording, M. S., & Iversen, L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1431 · Cited by 139 · see citing works
Wen, Y., Suter, M. R., Kawasaki, Y., Huang, J. L., Pertin, M., Kohno, T., Berde, C. B., Décosterd, I., & Ji, R. (2007) · Anesthesiology · doi:10.1097/01.anes.0000270759.11086.e7 · Cited by 137 · see citing works
Spinal p38β isoform mediates tissue injury‐induced hyperalgesia and spinal sensitization
Svensson, C. I., Fitzsimmons, B., Azizi, S., Powell, H. C., Hua, X., & Yaksh, T. L. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02996.x · Cited by 134 · see citing works
Feijoo, C., Campbell, D. G., Jakes, R., Goedert, M., & Cuenda, A. (2005) · Journal of Cell Science · doi:10.1242/jcs.01655 · Cited by 133 · see citing works
Rahman, M. S., Yamasaki, A., Yang, J., Shan, L., Halayko, A. J., & GOUNNI, A. S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.6.4064 · Cited by 133 · see citing works
The p38 Kinases MKK4 and MKK6 Suppress Metastatic Colonization in Human Ovarian Carcinoma
Hickson, J. A., Huo, D., Griend, D. J. V., Lin, A., Rinker-Schaeffer, C. W., & Yamada, S. D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3676 · Cited by 132 · see citing works
Activation of p38 MAPK is a key step in tumor necrosis factor–mediated inflammatory bone destruction
Zwerina, J., Hayer, S., Redlich, K., Bobacz, K., Kollias, G., Smolen, J. S., & Schett, G. A. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21626 · Cited by 132 · see citing works
Spinal blockade of TNF blocks spinal nerve ligation-induced increases in spinal P-p38
Svensson, C. I., Schäfers, M., Jones, T. L., et al. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2004.12.064 · Cited by 131 · see citing works
Regulation of Peripheral Inflammation by Spinal p38 MAP Kinase in Rats
Boyle, D. L., Jones, T. L., Hammaker, D. R., Svensson, C. I., Rosengren, S., Albani, S., Sorkin, L. S., & Firestein, G. S. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030338 · Cited by 130 · see citing works
Junttila, M. R., Ala‐aho, R., Jokilehto, T., Peltonen, J. T. K., Kallajoki, M. A., Grenman, R. A., Jaakkola, P., Westermarck, J. K., & Kähäri, V. (2007) · Oncogene · doi:10.1038/sj.onc.1210332 · Cited by 127 · see citing works
Ip, W., Wong, C. K., & Lam, C. W. K. (2006) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2006.03085.x · Cited by 125 · see citing works
Price, S. A., Agthong, S., Middlemas, A. B., & Tomlinson, D. R. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1851 · Cited by 123 · see citing works
Muniyappa, H., & Das, K. C. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.12.003 · Cited by 114 · see citing works
Lim, A. K. H., Nikolic‐Paterson, D. J., Ma, F. Y., Ozols, E., Thomas, M. C., Flavell, R. A., Davis, R. J., & Tesch, G. H. (2008) · Diabetologia · doi:10.1007/s00125-008-1215-5 · Cited by 113 · see citing works
MAPKs: new targets for neurodegeneration
Harper, S. J., & Wilkie, N. M. (2003) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.7.2.187 · Cited by 111 · see citing works
Xu, J., Xin, W., Wei, X., et al. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.11.016 · Cited by 110 · see citing works
Ip, W., Wong, C. K., Li, M. L. Y., Li, P. W., Cheung, P. F., & Lam, C. W. K. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02668.x · Cited by 110 · see citing works
Inoue, T., Boyle, D. L., Corr, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509188103 · Cited by 110 · see citing works
Critical role of nuclear factor‐κB and stress‐activated protein kinases in steroid unresponsiveness
Bantel, H., Schmitz, M. L., Raible, A., Gregor, M., & Schulze‐Osthoff, K. (2002) · The FASEB Journal · doi:10.1096/fj.02-0223fje · Cited by 107 · see citing works
IL-17 enhances IL-1β-mediated CXCL-8 release from human airway smooth muscle cells
Dragon, S., Rahman, M. S., Yang, J., Unruh, H. W., Halayko, A. J., & GOUNNI, A. S. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00306.2006 · Cited by 107 · see citing works
The p38 MAP kinase signaling pathway in Alzheimer's disease
Johnson, G. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00268-1 · Cited by 106 · see citing works
IL-17A acts via p38 MAPK to increase stability of TNF-α-induced IL-8 mRNA in human ASM
Henness, S., van Thoor, E., Ge, Q., Armour, C. L., Hughes, J. M., & Ammit, A. J. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00367.2005 · Cited by 98 · see citing works
Amin, M. A., Mansfield, P. J., Pákozdi, A., Campbell, P. L., Ahmed, S., Martinez, R. J., & Koch, A. E. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22705 · Cited by 97 · see citing works
Gorska, M. M., Liang, Q., Stafford, S. J., Goplen, N., Dharajiya, N. G., Guo, L., Sur, S. A., Gaestel, M., & Alam, R. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062621 · Cited by 97 · see citing works
Microbicidal protein psoriasin is a multifunctional modulator of neutrophil activation
Zheng, Y., Niyonsaba, F., Ushio, H., Ikeda, S., Nagaoka, I., Okumura, K., & Ogawa, H. (2008) · Immunology · doi:10.1111/j.1365-2567.2007.02782.x · Cited by 93 · see citing works
Subramanian, S., Rhodes, J. M., Hart, A. C., Tam, B., Roberts, C. L., Smith, S. L., CORKILL, J. E., Winstanley, C., Virji, M., & Campbell, B. J. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20296 · Cited by 91 · see citing works
Ellinger-Ziegelbauer, H. C., Kelly, K., & Siebenlist, U. K. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3857 · Cited by 85 · see citing works
Martindale, J. J., Wall, J. A., Martinez-Longoria, D. M., Aryal, P., Rockman, H. A., Guo, Y., Bolli, R., & Glembotski, C. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406690200 · Cited by 85 · see citing works
Pruitt, K., Pruitt, W. M., Bilter, G. K., Westwick, J. K., & Der, C. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203964200 · Cited by 84 · see citing works
Positive crosstalk between ERK and p38 in melanoma stimulates migration and in vivo proliferation
Estrada, Y. D., Dong, J., & Ossowski, L. (2008) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2008.00520.x · Cited by 84 · see citing works
Targeting p38-MAPK in the ischaemic heart: kill or cure?
BASSI, R., Heads, R. J., Marber, M. S., & Clark, J. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.01.002 · Cited by 83 · see citing works
Medicherla, S., Jing, Y., Mangadu, R., Jiang, Y., Zhao, J. J., Almirez, R. G., Kerr, I., Stebbins, E. G., O’Young, G., Kapoun, A. M., et al. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.098020 · Cited by 83 · see citing works
Thomas, T. A., Timmer, M., Cesnulevicius, K., Hitti, E., Kotlyarov, A., & Gaestel, M. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05310.x · Cited by 81 · see citing works
Yu, X., Li, C., Dai, H.-Y., Cai, D., Wang, K.-Y., Xu, Y.-H., Chen, L., & Zhou, C.-L. (2007) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2007.05.002 · Cited by 78 · see citing works
MNK kinases regulate multiple TLR pathways and innate proinflammatory cytokines in macrophages
Rowlett, R. M., Chrestensen, C. A., Nyce, M. R., Harp, M. G., Pelo, J. W., Cominelli, F., Ernst, P. B., Pizarro, T. T., Sturgill, T. W., & Worthington, M. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00077.2007 · Cited by 78 · see citing works
Regulation of p38 MAPK by MAPK Kinases 3 and 6 in Fibroblast-Like Synoviocytes
Inoue, T., Hammaker, D. R., Boyle, D. L., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.7.4301 · Cited by 69 · see citing works
Ospelt, C., Brentano, F., Jüngel, A., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24226 · Cited by 69 · see citing works
Gesser, B., Johansen, C., Rasmussen, M. K., et al. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700859 · Cited by 68 · see citing works
Pongratz, G., McAlees, J. W., Conrad, D. H., Erbe, R. S., Haas, K. M., & Sanders, V. M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.5.2926 · Cited by 67 · see citing works
Tudhope, S. J., Finney‐Hayward, T. K., Nicholson, A. G., Mayer, R. J., Barnette, M. S., Barnes, P. J., & Donnelly, L. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.127670 · Cited by 67 · see citing works
p38 MAPK Signaling in Oral-related Diseases
Patil, C. S., & Kirkwood, K. L. (2007) · Journal of Dental Research · doi:10.1177/154405910708600903 · Cited by 66 · see citing works
Kim, H. J., Oh, J. E., Kim, S. W., Chun, Y. J., & Kim, M. Y. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.10.030 · Cited by 66 · see citing works
Discovery of Highly Selective and Potent p38 Inhibitors Based on a Phthalazine Scaffold
Herberich, B., Cao, G., Chakrabarti, P., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8005417 · Cited by 61 · see citing works
Park, H.-J., Kim, H. J., Lee, J. H., Lee, J. Y., Cho, B. K., Kang, J. S., Kang, H., Yang, Y. D., & Cho, D. H. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23656.x · Cited by 61 · see citing works
Brechter, A. B., & Lerner, U. H. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22445 · Cited by 61 · see citing works
Biphenyl amide p38 kinase inhibitors 4: DFG-in and DFG-out binding modes
Angell, R. M., Angell, T. D., Bamborough, P., Bamford, M. J., Chung, C., Cockerill, S. G., Flack, S. S., Jones, K. L., Lainé, D. I., Longstaff, T., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.06.028 · Cited by 58 · see citing works
Otkjær, K., Kragballe, K., Johansen, C., et al. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700713 · Cited by 58 · see citing works
Serum amyloid A‐induced IL‐6 production by rheumatoid synoviocytes
Koga, T., Torigoshi, T., Motokawa, S., Miyashita, T., Maeda, Y., Nakamura, M., Komori, A., Aiba, Y., Uemura, T., Yatsuhashi, H., et al. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.01.022 · Cited by 57 · see citing works
Lim, E. J., Jeon, H., Yang, G. Y., et al. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.05.016 · Cited by 49 · see citing works
Renal p38 MAP kinase activity in experimental diabetes
Komers, R., Lindsley, J. N., Oyama, T., Cohen, D., & Anderson, S. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700549 · Cited by 48 · see citing works
A Subtle Change in p38 MAPK Activity is Sufficient to Suppress In Vivo Tumorigenesis
Timofeev, O. N., Lee, T. Y., & Bulavin, D. V. (2004) · Cell Cycle · doi:10.4161/cc.4.1.1342 · Cited by 44 · see citing works
Waetzig, G. H., Rosenstiel, P. C., Nikolaus, S., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00979-x · Cited by 42 · see citing works
Zer, C., Sachs, G. M., & Shin, J. M. (2007) · Physiological Genomics · doi:10.1152/physiolgenomics.00080.2007 · Cited by 41 · see citing works
Funding, A. T., Johansen, C., Kragballe, K., et al. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700821 · Cited by 41 · see citing works
Harigai, M., Hara, M., Kawamoto, M., Kawaguchi, Y., Sugiura, T., Tanaka, M., Nakagawa, M., Ichida, H., Takagi, K., Higami-Ohsako, S., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20340 · Cited by 37 · see citing works
Suppressive effects of ketotifen on Th1‐ and Th2‐related chemokines of monocytes
Hung, C., Suen, J., Hua, Y., et al. (2007) · Pediatric Allergy and Immunology · doi:10.1111/j.1399-3038.2007.00535.x · Cited by 34 · see citing works
Stassen, M., KLEIN, M., Becker, M. A., Bopp, T., Neudörfl, C., RICHTER, C., Heib, V., KLEINHESSLING, S., Serfling, E., & Schild, H. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.03.019 · Cited by 34 · see citing works
Koch, A., Raidl, M., Lux, M. P., et al. (2006) · Respiratory Medicine · doi:10.1016/j.rmed.2006.10.010 · Cited by 21 · see citing works
Whittall, T., Wang, Y., Kelly, C. G., et al. (2006) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2006.03010.x · Cited by 21 · see citing works
Wada, Y., Shimada, K., Kimura, T., & Ushiyama, S. (2005) · Immunology Letters · doi:10.1016/j.imlet.2005.04.010 · Cited by 16 · see citing works
Noel, J. K., Crean, S. M., Claflin, J. E., et al. (2008) · Medical Oncology · doi:10.1007/s12032-008-9039-1 · Cited by 15 · see citing works
Investigations of SCIO-469-like compounds for the inhibition of p38 MAP kinase
Laufer, S., & Lehmann, F. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.01.023 · Cited by 15 · see citing works
Okuma-Yoshioka, C., Seto, H., Kadono, Y., et al. (2008) · Modern Rheumatology · doi:10.1007/s10165-008-0069-5 · Cited by 14 · see citing works
桂, 弘. (2007) · Medical Entomology and Zoology · Cited by 13 · see citing works
p38 MAP Kinase Mediated Proteoglycan Synthesis as a Target for the Prevention of Atherosclerosis
Osman, N., Ballinger, M. L., Dadlani, H., Getachew, R., Burch, M. L., & Little, P. J. (2008) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/187152908786786205 · Cited by 12 · see citing works
Tong, S., Daniels, S., Montano, T., et al. (2004) · Journal of Pain · doi:10.1016/j.jpain.2004.02.284 · Cited by 1 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Salminen, A., Kauppinen, A., & Kaarniranta, K. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2011.12.006 · Cited by 763 · see citing works
Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligase
Smith, B. E., Wang, S. L., Jaime-Figueroa, S., Harbin, A., Wang, J., Hamman, B. D., & Crews, C. M. (2019) · Nature Communications · doi:10.1038/s41467-018-08027-7 · Cited by 517 · see citing works
Kinase inhibition in autoimmunity and inflammation
Zarrin, A. A., Bao, K., Lupardus, P., & Vucic, D. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0082-8 · Cited by 431 · see citing works
Molecular basis of MAP kinase regulation
Peti, W., & Page, R. (2013) · Protein Science · doi:10.1002/pro.2374 · Cited by 302 · see citing works
“However, MAPK activation is finely tuned in a cell-type specific and temporal manner, making MAPK regulators much more attractive targets for drug development.(7) These regulators include: (1) upstream kinases, (2) downstream phosphatases, and (3) scaffolding proteins.”
BackgroundThe Innate Immune System in Acute and Chronic Wounds
MacLeod, A. S., & Mansbridge, J. N. (2016) · Advances in Wound Care · doi:10.1089/wound.2014.0608 · Cited by 289 · see citing works
“The p38/Jun stress pathway is activated by PAMPs and DAMPs, leading to the secretion of inflammatory cytokines, such as IL-1, TNF, and IL-6.”
BackgroundPerdiguero, E., Sousa-Victor, P., Ruiz-Bonilla, V., Jardí, M., Caelles, C., Serrano, A. L., & Muñoz-Cánoves, P. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201104053 · Cited by 236 · see citing works
Galliher-Beckley, A. J., Williams, J. G., & Cidlowski, J. A. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05866-11 · Cited by 164 · see citing works
Dietary phytochemicals and neuro-inflammaging: from mechanistic insights to translational challenges
Davinelli, S., Maes, M., Corbi, G., Zarrelli, A., Willcox, D. C., & Scapagnini, G. (2016) · Immunity & Ageing · doi:10.1186/s12979-016-0070-3 · Cited by 122 · see citing works
Figueiredo, V. C., Roberts, L. A., Markworth, J. F., Barnett, M. P. G., Coombes, J. S., Raastad, T., Peake, J. M., & Cameron-Smith, D. (2016) · Physiological Reports · doi:10.14814/phy2.12670 · Cited by 104 · see citing works
Shan, F., Shao, Z., Jiang, S., & Cheng, Z. (2016) · Cancer Medicine · doi:10.1002/cam4.881 · Cited by 88 · see citing works
P38β MAPK Upregulates Atrogin1/MAFbx by Specific Phosphorylation of C/EBPβ
Zhang, G., & Li, Y.-P. (2012) · Skeletal Muscle · doi:10.1186/2044-5040-2-20 · Cited by 53 · see citing works
Perdiguero, E., Kharraz, Y., Serrano, A. L., & Muñoz-Cánoves, P. (2012) · Cell Cycle · doi:10.4161/cc.11.5.19374 · Cited by 30 · see citing works
Xiao, Y., Wang, J., Yan, W., Zhou, K., Cao, Y., & Cai, W. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.523 · Cited by 29 · see citing works
NMR Spectroscopic Investigations of the Activated p38α Mitogen‐Activated Protein Kinase
Nielsen, G., & Schwalbe, H. (2011) · ChemBioChem · doi:10.1002/cbic.201100527 · Cited by 15 · see citing works
Albumin-binding RNAi Conjugate for Carrier Free Treatment of Arthritis
Colazo, J. M., Hoogenboezem, E. N., Keech, M. C., Francini, N., Shah, V., Yu, F., Lo, J. H., Sorets, A. G., McCune, J. T., Cho, H., et al. (2023) · doi:10.1101/2023.05.31.542971 · Cited by 11 · see citing works
- Authors
- Coulthard, L. R., White, D. E., Jones, D. L., McDermott, M. F., & Burchill, S. A.
- Affiliations
- St James's University Hospital (GB)
- Corresponding author
- Burchill, Susan A.
- Venue
- Trends in Molecular Medicine
- Publisher
- Elsevier BV
- Published
- 2009-08
- Volume
- 15
- Issue
- 8
- Pages
- 369-379
- ISSN
- 1471-4914 (ISSN-L)
- PMC
- PMC3016890
- OpenAlex
- W2079749507
- Cited by
- 691
- References
- 130
- Citations by year
- 2026: 46 · 2025: 55 · 2024: 68 · 2023: 64 · 2022: 56 · 2021: 47 · 2020: 43 · 2019: 29 · 2018: 28 · 2017: 36 · 2016: 28 · 2015: 28 · 2014: 28 · 2013: 35 · 2012: 34
- FWCI
- 2.55
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Trends in Molecular Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Versus Arthritis (17855)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Keywords
- p38 MAPK, MAPK signaling, stress response, inflammation, cell cycle regulation, cell death, senescence, carcinogenesis, protein kinase inhibitors, drug development
- MeSH terms
- Animals, Humans, Immunity, Therapeutics, Signal Transduction, p38 Mitogen-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review